Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD, ACTIV-4a Investigators.

Open source

DOI
10.1001/jama.2021.23605
Published
2022-01-01
Container
JAMA
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2021.23605,
  title = {Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.},
  author = {Berger JS and  Kornblith LZ and  Gong MN and  Reynolds HR and  Cushman M and  Cheng Y and  McVerry BJ and  Kim KS and  Lopes RD and  Atassi B and  Berry S and  Bochicchio G and  de Oliveira Antunes M and  Farkouh ME and  Greenstein Y and  Hade EM and  Hudock K and  Hyzy R and  Khatri P and  Kindzelski A and  Kirwan BA and  Baumann Kreuziger L and  Lawler PR and  Leifer E and  Lopez-Sendon Moreno J and  Lopez-Sendon J and  Luther JF and  Nigro Maia L and  Quigley J and  Sherwin R and  Wahid L and  Wilson J and  Hochman JS and  Neal MD and  ACTIV-4a Investigators.},
  year = {2022},
  journal = {JAMA},
  doi = {10.1001/jama.2021.23605},
  url = {https://doi.org/10.1001/jama.2021.23605}
}

RIS

TY  - JOUR
TI  - Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
AU  - Berger JS
AU  -  Kornblith LZ
AU  -  Gong MN
AU  -  Reynolds HR
AU  -  Cushman M
AU  -  Cheng Y
AU  -  McVerry BJ
AU  -  Kim KS
AU  -  Lopes RD
AU  -  Atassi B
AU  -  Berry S
AU  -  Bochicchio G
AU  -  de Oliveira Antunes M
AU  -  Farkouh ME
AU  -  Greenstein Y
AU  -  Hade EM
AU  -  Hudock K
AU  -  Hyzy R
AU  -  Khatri P
AU  -  Kindzelski A
AU  -  Kirwan BA
AU  -  Baumann Kreuziger L
AU  -  Lawler PR
AU  -  Leifer E
AU  -  Lopez-Sendon Moreno J
AU  -  Lopez-Sendon J
AU  -  Luther JF
AU  -  Nigro Maia L
AU  -  Quigley J
AU  -  Sherwin R
AU  -  Wahid L
AU  -  Wilson J
AU  -  Hochman JS
AU  -  Neal MD
AU  -  ACTIV-4a Investigators.
PY  - 2022
JO  - JAMA
DO  - 10.1001/jama.2021.23605
UR  - https://doi.org/10.1001/jama.2021.23605
ER  - 

APA

JS, B., LZ, K., MN, G., HR, R., M, C., Y, C., BJ, M., KS, K., RD, L., B, A., S, B., G, B., M, D. O. A., ME, F., Y, G., EM, H., K, H., R, H., P, K., A, K., BA, K., L, B. K., PR, L., E, L., J, L. M., J, L., JF, L., L, N. M., J, Q., R, S., L, W., J, W., JS, H., MD, N., & Investigators., A. (2022). Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2021.23605

Source records